MEMBDEATH: Muerte celular y membranas: un nuevo nicho en la lucha contra el cáncer. Colab con la UV, no recibimos financiación
Datos básicos
- Código Financiador:
- Año inicial:
- 2019
- Año final:
- 2022
Documentos
- No hay documentos
Participantes
Grupos de Investigación
Financiadores
Resultados del Proyecto
A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG
Hernández-Montoto A; (...); Sancenón F
Article. 10.1039/c9cc04260a. 2019
BOK-MCL1 transmembrane interactions: a challenging target for cancer therapy
Editorial Material. 10.1080/23723556.2020.1859918. 2021
Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.
Estepa-Fernández A; (...); Martínez-Máñez R
Article. 10.1016/j.phrs.2022.106628. 2023
Dinoponera quadriceps venom as a source of active agents against Staphylococcus aureus
Rocha, LQ; (...); Martins, AMC
Article. 10.1016/j.toxicon.2020.11.003. 2021
EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
Brennecke, P; (...); Gribbon, P
Article. 10.1177/2472555218816276. 2019
Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells
Candela-Noguera, V; (...); Martinez-Manez, R
Article. 10.3390/nano11051298. 2021
Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy
Vivo-Llorca, G; (...); Martinez-Manez, R
Article. 10.2147/IJN.S323802. 2022
Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases
Soriano-Teruel, PM; (...); Orzaez, M
Article. 10.1038/s41419-021-04420-1. 2021
Identification of NLRP3(PYD) Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity
Ghafary, SM; (...); Hosseinkhani, S
Article. 10.3390/ijms23031651. 2022
Janus Gold Nanostars-Mesoporous Silica Nanoparticles for NIR-Light-Triggered Drug Delivery
Hernández Montoto A; (...); Sancenón F
Article. 10.1002/chem.201900750. 2019
Mcl-1 and Bok transmembrane domains: Unexpected players in the modulation of apoptosis.
Lucendo E; (...); Orzáez M
Article. 10.1073/pnas.2008885117. 2020
MUC1 Aptamer-Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple-Negative Breast Cancer
Vivo-Llorca, G; (...); Martinez-Manez, R
Article. 10.1002/chem.202001579. 2020
Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy
Garcia-Fernandez, A; (...); Martinez-Manez, R
Article. 10.3390/pharmaceutics14071495. 2022
Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice
Lerida-Viso, A; (...); Martinez-Manez, R
Article. 10.1016/j.phrs.2022.106356. 2022
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic.
Galiana I; (...); Orzáez M
Article. 10.1016/j.jconrel.2020.04.045. 2020
Rational design of a trypanocidal peptide derived from Dinoponera quadriceps venom.
Monteiro ML; (...); Martins AMC
Article. 10.1016/j.ejmech.2022.114624. 2022
Real-Time In Vivo Detection of Cellular Senescence through the Controlled Release of the NIR Fluorescent Dye Nile Blue
Lozano-Torres, B; (...); Martinez-Manez, R
Article. 10.1002/anie.202004142. 2020
Senolysis Reduces Senescence in Veins and Cancer Cell Migration
Estepa-Fernandez, A; (...); Martinez-Manez, R
Article. 10.1002/adtp.202100149. 2021
Split-luciferase complementary assay of NLRP3 PYD-PYD interaction indicates inflammasome formation during inflammation.
Isazadeh M; (...); Hosseinkhani S
Article. 10.1016/j.ab.2021.114510. 2022
Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles. A new therapeutic approach for acute lung injury treatment.
García-Fernández A; (...); Martínez-Máñez R
Article. 10.1016/j.jconrel.2021.07.010. 2021
The chemistry of senescence
Lozono-Torres, B; (...); Sancenon, F
Review. 10.1038/s41570-019-0108-0. 2019
The past, present, and future of breast cancer models for nanomedicine development
Boix-Montesinos, P; (...); Vicent, MJ
Review. 10.1016/j.addr.2021.03.018. 2021
Understanding MCL1: from cellular function and regulation to pharmacological inhibition
Review. 10.1111/febs.16136. 2022